Strongbridge Biopharma plc Announces $35 Million Equity Financing
Dec 23, 2016 13:00 pm UTC| Business
DUBLIN, Ireland and TREVOSE, Pa., Dec. 23, 2016 -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare...
Dec 23, 2016 13:00 pm UTC| Business
SAN DIEGO, Dec. 23, 2016 -- Neothetics, Inc. (NASDAQ:NEOT) today announced the initiation of the Phase 2 proof of concept trial, LIPO-202-CL-31, for LIPO-202 for the reduction of submental subcutaneous fat. “The...
Amicus Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
Dec 23, 2016 12:30 pm UTC| Business
CRANBURY, N.J., Dec. 23, 2016 -- Amicus Therapeutics (Nasdaq:FOLD), a global biotechnology company at the forefront of therapies for rare and orphan diseases, today announced that John F. Crowley, Chairman and Chief...
Global Fabry Disease Drugs Price Analysis and Strategies Report 2016-2021
Dec 23, 2016 12:22 pm UTC| Business
Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Fabry Disease Drugs Price Analysis and Strategies - 2016" report to their offering. Fabry Disease...
World Gonorrhoea Drugs Price Analysis and Strategies Report 2012-2021
Dec 23, 2016 12:22 pm UTC| Business
Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Gonorrhoea Drugs Price Analysis and Strategies - 2016" report to their offering. Gonorrhoea Drugs...
Dec 23, 2016 12:20 pm UTC| Business
Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Medical Ultrasound Devices: Technologies and Global Markets" report to their offering. This report...
World Thalassaemia Drugs Price Analysis and Strategies 2012-2021
Dec 23, 2016 12:19 pm UTC| Business
Dublin, Dec. 23, 2016 -- Research and Markets has announced the addition of the "Thalassaemia Drugs Price Analysis and Strategies - 2016" report to their offering. Thalassaemia...